97 related articles for article (PubMed ID: 18055024)
1. Connecting chemosensitivity, gene expression and disease.
Covell DG
Trends Pharmacol Sci; 2008 Jan; 29(1):1-5. PubMed ID: 18055024
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell-based genomic and small molecule screens.
Caldwell JS
Adv Cancer Res; 2007; 96():145-73. PubMed ID: 17161679
[TBL] [Abstract][Full Text] [Related]
3. Chemical genetics-based target identification in drug discovery.
Cong F; Cheung AK; Huang SM
Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
[TBL] [Abstract][Full Text] [Related]
4. Genomic medicines for oncology: early lessons.
Simons JW
J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
[No Abstract] [Full Text] [Related]
5. Computational chemistry approaches to drug discovery in signal transduction.
Fischer PM
Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
[TBL] [Abstract][Full Text] [Related]
6. A systems biology approach to drug discovery.
Zhu J; Zhang B; Schadt EE
Adv Genet; 2008; 60():603-35. PubMed ID: 18358334
[TBL] [Abstract][Full Text] [Related]
7. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds.
De Preter K; De Brouwer S; Van Maerken T; Pattyn F; Schramm A; Eggert A; Vandesompele J; Speleman F
Clin Cancer Res; 2009 Jun; 15(11):3690-6. PubMed ID: 19435837
[TBL] [Abstract][Full Text] [Related]
8. Beyond clinical phenotype: the biologic integratome.
Grimaldi D; Claessens YE; Mira JP; Chiche JD
Crit Care Med; 2009 Jan; 37(1 Suppl):S38-49. PubMed ID: 19104224
[TBL] [Abstract][Full Text] [Related]
9. Seeing small molecules in action with bioorthogonal chemistry.
Raghavan AS; Hang HC
Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic gene clusters as drug action mechanisms].
Tanaka T
Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():5P-7P. PubMed ID: 14727507
[TBL] [Abstract][Full Text] [Related]
11. Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures.
Braconi C; Meng F; Swenson E; Khrapenko L; Huang N; Patel T
Cancer; 2009 Aug; 115(16):3738-48. PubMed ID: 19514085
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
13. Applications of aptamers in cancer cell biology.
Phillips JA; Lopez-Colon D; Zhu Z; Xu Y; Tan W
Anal Chim Acta; 2008 Jul; 621(2):101-8. PubMed ID: 18573375
[TBL] [Abstract][Full Text] [Related]
14. Gene expression trends and protein features effectively complement each other in gene function prediction.
Wabnik K; Hvidsten TR; Kedzierska A; Van Leene J; De Jaeger G; Beemster GT; Komorowski J; Kuiper MT
Bioinformatics; 2009 Feb; 25(3):322-30. PubMed ID: 19050035
[TBL] [Abstract][Full Text] [Related]
15. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
16. Genomics in drug discovery: the best things come to those who wait.
Bansal AT; Barnes MR
Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
[TBL] [Abstract][Full Text] [Related]
17. The application of RAGE and GECKO in cell-based target discovery screens.
Brunden K; Sherf B; Harrington J
Pharmacogenomics; 2005 Jun; 6(4):383-92. PubMed ID: 16004556
[TBL] [Abstract][Full Text] [Related]
18. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
19. Is chemical genetics the new frontier for malaria biology?
Greenbaum DC
Trends Pharmacol Sci; 2008 Feb; 29(2):51-6. PubMed ID: 18199489
[TBL] [Abstract][Full Text] [Related]
20. Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary.
Wang SJ; Cohen N; Katz DA; Ruano G; Shaw PM; Spear B
Pharmacogenomics J; 2006; 6(2):82-8. PubMed ID: 16402078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
